| Literature DB >> 354047 |
Abstract
Trials of a new schistosomicide oxamniquine (Vansil) were carried out in the lowveld of the Eastern Transvaal. After initial dose-finding trials, the safety and efficacy of oxamniquine against Schistosoma mansoni at an oral dose of 15 mg/kg twice a day for 2 days (total dose 60 mg/kg), were confirmed. No detectable effect was noted against S. haematobium or S. mattheei.Entities:
Mesh:
Substances:
Year: 1978 PMID: 354047
Source DB: PubMed Journal: S Afr Med J